Historique
Bulletin de Périodique
European Addiction Research , Vol.24, n°1 - March 2018
Paru le :
01/03/2018
Année
2018
Page(s) :
1-52
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Mentalization-based treatment for concurrent borderline personality disorder and substance use disorder: A randomized controlled feasibility study. Philips B., Wennberg P., Konradsson P., Franck J., p. 1-8.
- Methadone dose adjustments, plasma R-methadone levels and therapeutic outcome of heroin users: A randomized clinical trial. Mannaioni G., Lanzi C., Lotti M., Galli V., Totti A., Pacileo I., et al., p. 9-18.
- Intellectual functioning in in-patients with substance use disorders: Preliminary results from a clinical mediation study of factors contributing to IQ Variance. Braatveit K.J., Torsheim T., Hove O., p. 19-27.
- Impact of health authority control measures aimed at reducing the illicit use of anabolic-androgenic steroids. Vazquez-Mourelle R., Carracedo-Martinez E., Figueiras A., p. 28-36.
- Age invariance of the Cannabis Abuse Screening Test in a probabilistic sample of cannabis users. Legleye S., Rouquette A., p. 37-42.
- International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder. Crunelle C.L., van den Brink W., Moggi F., Konstenius M., Franck J., Levin F.R., et al., p. 43-51.
- Mentalization-based treatment for concurrent borderline personality disorder and substance use disorder: A randomized controlled feasibility study. Philips B., Wennberg P., Konradsson P., Franck J., p. 1-8.
- Methadone dose adjustments, plasma R-methadone levels and therapeutic outcome of heroin users: A randomized clinical trial. Mannaioni G., Lanzi C., Lotti M., Galli V., Totti A., Pacileo I., et al., p. 9-18.
- Intellectual functioning in in-patients with substance use disorders: Preliminary results from a clinical mediation study of factors contributing to IQ Variance. Braatveit K.J., Torsheim T., Hove O., p. 19-27.
- Impact of health authority control measures aimed at reducing the illicit use of anabolic-androgenic steroids. Vazquez-Mourelle R., Carracedo-Martinez E., Figueiras A., p. 28-36.
- Age invariance of the Cannabis Abuse Screening Test in a probabilistic sample of cannabis users. Legleye S., Rouquette A., p. 37-42.
- International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder. Crunelle C.L., van den Brink W., Moggi F., Konstenius M., Franck J., Levin F.R., et al., p. 43-51.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
S. LEGLEYE ;
A. ROUQUETTE
|
2018
Dans European Addiction Research (Vol.24, n°1, March 2018) Article : Périodique
Dans European Addiction Research (Vol.24, n°1, March 2018) Article : Périodique
The Cannabis abuse screening test (CAST) is a short test used for screening those with problematic cannabis use. Recently, its invariance toward age was tested in an Israeli sample of cannabis users, but this study had some sample and methodolog[...]